Biodesix, Inc. (BDSX)

NASDAQ: BDSX · IEX Real-Time Price · USD
-0.02 (-0.83%)
At close: Jan 31, 2023, 4:00 PM
+0.25 (10.42%)
Pre-market: Feb 1, 2023, 8:00 AM EST

Total Valuation

Biodesix has a market cap or net worth of $183.59 million. The enterprise value is $191.92 million.

Market Cap 183.59M
Enterprise Value 191.92M

Important Dates

The next earnings date is Monday, March 13, 2023, after market close.

Estimated Earnings Date Mar 13, 2023
Ex-Dividend Date n/a

Share Statistics

Biodesix has 76.50 million shares outstanding. The number of shares has increased by 44.19% in one year.

Shares Outstanding 76.50M
Shares Change (YoY) +44.19%
Shares Change (QoQ) +3.08%
Owned by Insiders (%) 70.91%
Owned by Institutions (%) 6.35%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.12
Forward PS 3.43
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.36
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.65

Current Ratio 0.65
Quick Ratio 0.52
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -723.60% and return on invested capital (ROIC) is -798.80%.

Return on Equity (ROE) -723.60%
Return on Assets (ROA) -84.60%
Return on Capital (ROIC) -798.80%
Revenue Per Employee $164,353
Profits Per Employee -$267,849
Employee Count 218
Asset Turnover 0.52
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.84% in the last 52 weeks. The beta is 1.47, so Biodesix's price volatility has been higher than the market average.

Beta (1Y) 1.47
52-Week Price Change -37.84%
50-Day Moving Average 1.90
200-Day Moving Average 1.70
Average Volume (30 Days) 190,095

Short Selling Information

The latest short interest is 237,568, so 0.31% of the outstanding shares have been sold short.

Short Interest 237,568
Short Previous Month 280,937
Short % of Shares Out 0.31%
Short % of Float n/a
Short Ratio (days to cover) 1.66

Income Statement

In the last 12 months, Biodesix had revenue of $35.83 million and -$58.39 million in losses. Loss per share was -$1.73.

Revenue 35.83M
Gross Profit 22.49M
Operating Income -48.38M
Pretax Income -58.39M
Net Income -58.39M
EBITDA -46.32M
EBIT -51.37M
Loss Per Share -$1.73
Full Income Statement

Balance Sheet

The company has $15.18 million in cash and $23.51 million in debt, giving a net cash position of -$8.33 million or -$0.11 per share.

Cash & Cash Equivalents 15.18M
Total Debt 23.51M
Net Cash -8.33M
Net Cash Per Share -$0.11
Equity / Book Value -2.90M
Book Value Per Share -0.04
Working Capital -13.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.22 million and capital expenditures -$2.19 million, giving a free cash flow of -$45.41 million.

Operating Cash Flow -43.22M
Capital Expenditures -2.19M
Free Cash Flow -45.41M
FCF Per Share -$1.12
Full Cash Flow Statement


Gross margin is 62.76%, with operating and profit margins of -135.02% and -162.97%.

Gross Margin 62.76%
Operating Margin -135.02%
Pretax Margin -162.97%
Profit Margin -162.97%
EBITDA Margin -129.28%
EBIT Margin -143.38%
FCF Margin -126.74%

Dividends & Yields

Biodesix does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -31.81%
FCF Yield -24.73%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -44.19%
Shareholder Yield -44.19%
Dividend Details

Analyst Forecast

The average price target for Biodesix is $5.10, which is 112.50% higher than the current price. The consensus rating is "Buy".

Price Target $5.10
Price Target Difference 112.50%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a